Ko e hā e ʻuhinga ʻo e “Mahino”?
‘Oku ‘ikai ke ‘ave ‘e he manú ‘a e mutation. He ʻikai ke ne maʻu ʻa e mahakí . pea ‘e ‘ikai te ne paasi atu ia.
Kulī Ko e mahaki fakaʻauha ʻo e ʻAositelēliá (DMD-AL)
Discover the Australian Labradoodle Dystrophinopathy (DMD-AL) DNA test, an essential tool for dog breeders and owners. This genetic test identifies the presence of mutations linked to DMD-AL, a condition affecting muscle strength and health in Australian Labradoodles. Early detection through DMD-AL testing can help prevent the onset of symptoms and guide responsible breeding practices. Ensure your furry friend’s well-being by opting for this crucial DNA test. By understanding your dog’s genetic profile, you can make informed decisions that promote a healthier, happier life. Trust the DMD-AL DNA test for a proactive approach to your Australian Labradoodle's health. Take action today to safeguard your pet's future!
Fakanounou : DMD-AL
'Analaiso 'a e mutation : DMD c.2668C>T
Koloa ma'u tukufakaholo : X-Fehokotaki ki he Recessive
Fakanounou
DMD-AL
Tu'o lahi 'o e fakatokanga'i
Ko e mamafa fakafaito'o
Fakakalasi fakafaito'o
Ngaahi Mahaki Uoua
'Analaiso 'a e mutation
DMD c.2668C>T
p.(R890*)
p.(R890*)
Founga 'o e tofi'a .
X-Fehokotaki ki he Recessive
Hingoa kehe:
Duchenne Muscular Dystrophy In Australian Labradoodle
Fakanounou ʻo e siví:
The Australian Labradoodle Dystrophinopathy (DMD-AL) is a genetic condition affecting Australian Labradoodles, characterized by a deficiency in dystrophin, a protein essential for muscle function. This DNA test helps identify carriers of the mutation responsible for the disease, allowing breeders to make informed decisions and reduce its prevalence. Early detection through genetic testing can lead to better management strategies and ensure healthier breeding practices. Responsible breeding can significantly improve the quality of life for affected dogs, promoting overall breed health. Owners and breeders are encouraged to utilize this test to support the wellbeing of future generations of Australian Labradoodles.
Ma'u mei he pack : Basic
Ko e sivi DNA ko eni 'oku kau ia 'o kamata mei he'etau pack . Basic — pea ko e konga foki ia 'o e ngaahi pack . Basic, Standard, Advanced, Complete.
Vakai ki he Ngaahi Pack Sivi DNA →Fili 'a e pack 'oku fe'unga lelei taha mo ho'o fakatupu pe founga mo'ui lelei 'o ho'o fanga monumanu.
Understanding Australian Labradoodle Dystrophinopathy (DMD-AL)
Australian Labradoodle Dystrophinopathy (DMD-AL) is a genetic condition that affects the muscle function of Australian Labradoodles. This disorder is caused by mutations in the dystrophin gene, which is essential for maintaining the integrity of muscle fibers. As a result, affected dogs may experience progressive muscle weakness and degeneration, leading to significant mobility issues over time.
Symptoms of DMD-AL
Dogs with DMD-AL often exhibit a range of symptoms that can vary in severity. Common signs include difficulty in walking, reluctance to engage in physical activities, and noticeable muscle wasting. As the disease progresses, owners may observe a decline in the dog’s overall stamina and strength, which can severely impact their quality of life.
Diagnosis of DMD-AL
Diagnosis of DMD-AL typically involves a combination of clinical evaluation and genetic testing. Veterinarians may conduct physical examinations to assess muscle strength and function. Additionally, DNA testing can confirm the presence of the specific mutations associated with DMD-AL, providing a definitive diagnosis.
Mahu'inga 'o e Sivi DNA .
DNA testing for DMD-AL is crucial for breeders and dog owners alike. For breeders, it helps in making informed decisions to avoid producing affected puppies, thus contributing to the overall health of the breed. For owners, knowing whether their dog is a carrier or affected allows for better management of the condition and planning for future care needs.
Management of DMD-AL
Currently, there is no cure for DMD-AL, but management strategies can help improve the quality of life for affected dogs. This may include physical therapy, nutritional support, and regular veterinary check-ups to monitor the progression of the disease. Owners should work closely with their veterinarians to develop a tailored management plan that addresses the specific needs of their dog.
Aofangatuku
Understanding Australian Labradoodle Dystrophinopathy (DMD-AL) is essential for responsible dog ownership and breeding practices. DNA testing plays a vital role in identifying affected and carrier dogs, enabling proactive measures to promote the health and well-being of this beloved breed. Awareness and education about DMD-AL can significantly enhance the lives of both dogs and their owners.
Breed 'oku 'ilo'i ki he sivi : Ko e mahaki fakaʻauha ʻo e ʻAositelēliá (DMD-AL)
- Labradoodle
🧬 Interpretation of genotypes DMD-AL
Ko e genotype
Tu'unga
🟡 N/N
'Ikai fetuku - 'Ikai ha Fakatu'utamaki
❌ ♂ N/DMD-AL
Uesia - 'I he Fakatu'utamaki
🟡 ♀ N/DMD-AL
Fetuku - 'Ikai ha Fakatu'utamaki
❌ DMD-AL/DMD-AL
Uesia - 'I he Fakatu'utamaki
FAQ: mahino 'a e faka'uhinga
‘Oku fakamātoato ha “Kautaha”?
Ikai ‘Oku mo‘ui lelei fakalūkufua ‘a e manú ka ‘oku lava ke ne fakahoko ‘a e mutation ki hono . hako.
Fēfē kapau ‘oku “Uesia” ha monumanu?
‘Okú ne ‘ave ha ongo tatau kuo liliu. 'Oku 'amanaki ke 'asi mai 'a e ngaahi faka'ilonga fakafaito'o 'o makatu'unga 'i he . ko e mahaki. ʻOku ʻikai totonu ke fakatupu ia.
Ko e ha 'oku faikehekehe ai 'a e tangata / fefine?
Ko e ngaahi mahaki ‘e ni‘ihi ‘oku fehokotaki ia mo e fehokotaki fakasinó, ko ia ‘oku kehekehe ‘enau fakahaa‘í ‘o fakatatau ki he . fehokotaki fakasino ‘o e monumanu.
Fakafuofuaʻi ʻa e Hakó
N/N (ikai-fetuku)
N/DMD-AL (Fetuku)
DMD-AL/DMD-AL (Kuo uesia)
FAQ Sivi DNA
Ko e hā ‘oku ‘ilo‘i ‘e he sivi DNA ko ení?
This DNA test detects the mutation associated with Australian Labradoodle Dystrophinopathy (DMD) in order to identify clear, carrier, or at-risk animals.
Ko e hā ke sivi‘i ai ha monumanu fakafanaú?
‘Oku tokoni‘i ‘e he sivi DNA ‘a e kau tauhí ke nau palani ‘a e ngaahi fehokotaki malu ange pea fakasi‘isi‘i ‘a e fakatu‘utāmaki ‘o hono fakahoko ‘o e mutation ki he fānaú.
Ko e hā ‘a e founga tofi‘a ‘o e sivi ko ení?
Ko e founga tofi'a 'oku lipooti ki he sivi ko 'eni ko e X-Fehokotaki Recessive.
Ko e hā ‘a e mutation ‘oku ‘analaiso ‘i he sivi ko ení?
This test analyses the mutation DMD c.2668C>T.
‘Oku pau ‘oku uesia ha monumanu fetuku?
ʻOku ʻikai pau. 'Oku makatu'unga 'a e faka'uhinga 'i he founga 'o e tofi'a mo e genotype 'oku ma'u mei ai.
Ngaahi Maʻuʻanga Tokoni
Shrader Stephanie M, Jung SeungWoo, Denney Thomas S, Smith Bruce F. Characterization of Australian Labradoodle dystrophinopathy. Neuromuscul Disord. 2018 Nov;28(11):927-937. doi: 10.1016/j.nmd.2018.08.008. Epub 2018 Aug 29.